Cargando…

Congenital anomalies and associated risk factors in a Saudi population: a cohort study from pregnancy to age 2 years

OBJECTIVE: To assess the three key issues for congenital anomalies (CAs) prevention and care, namely, CA prevalence, risk factor prevalence and survival, in a longitudinal cohort in Riyadh, Saudi Arabia. SETTING: Tertiary care centre, Riyadh, Saudi Arabia. PARTICIPANTS: Saudi women enrolled during p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurdi, Ahmed M, Majeed-Saidan, Muhammad Ali, Al Rakaf, Maha S, AlHashem, Amal M, Botto, Lorenzo D, Baaqeel, Hassan S, Ammari, Amer N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731804/
https://www.ncbi.nlm.nih.gov/pubmed/31492776
http://dx.doi.org/10.1136/bmjopen-2018-026351
_version_ 1783449735183466496
author Kurdi, Ahmed M
Majeed-Saidan, Muhammad Ali
Al Rakaf, Maha S
AlHashem, Amal M
Botto, Lorenzo D
Baaqeel, Hassan S
Ammari, Amer N
author_facet Kurdi, Ahmed M
Majeed-Saidan, Muhammad Ali
Al Rakaf, Maha S
AlHashem, Amal M
Botto, Lorenzo D
Baaqeel, Hassan S
Ammari, Amer N
author_sort Kurdi, Ahmed M
collection PubMed
description OBJECTIVE: To assess the three key issues for congenital anomalies (CAs) prevention and care, namely, CA prevalence, risk factor prevalence and survival, in a longitudinal cohort in Riyadh, Saudi Arabia. SETTING: Tertiary care centre, Riyadh, Saudi Arabia. PARTICIPANTS: Saudi women enrolled during pregnancy over 3 years and their 28 646 eligible pregnancy outcomes (births, stillbirths and elective terminations of pregnancy for foetal anomalies). The nested case-control study evaluated the CA risk factor profile of the underlying cohort. All CA cases (1179) and unaffected controls (1262) were followed through age 2 years. Referred mothers because of foetal anomaly and mothers who delivered outside the study centre and their pregnancy outcome were excluded. PRIMARY OUTCOME MEASURES: Prevalence and pattern of major CAs, frequency of CA-related risk factors and survival through age 2 years. RESULTS: The birth prevalence of CAs was 412/10 000 births (95% CI 388.6 to 434.9), driven mainly by congenital heart disease (148 per 10 000) (95% CI 134 to 162), renal malformations (113, 95% CI 110 to 125), neural tube defects (19, 95% CI 25.3 to 38.3) and chromosomal anomalies (27, 95% CI 21 to 33). In this study, the burden of potentially modifiable risk factors included high rates of diabetes (7.3%, OR 1.98, 95% CI 1.04 to 2.12), maternal age >40 years (7.0%, OR 2.1, 95% CI 1.35 to 3.3), consanguinity (54.5%, OR 1.5, 95% CI 1.28 to 1.81). The mortality for live births with CAs at 2 years of age was 15.8%. CONCLUSIONS: This study documented specific opportunities to improve primary prevention and care. Specifically, folic acid fortification (the neural tube defect prevalence was >3 times that theoretically achievable by optimal fortification), preconception diabetes screening and consanguinity-related counselling could have significant and broad health benefits in this cohort and arguably in the larger Saudi population.
format Online
Article
Text
id pubmed-6731804
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67318042019-09-20 Congenital anomalies and associated risk factors in a Saudi population: a cohort study from pregnancy to age 2 years Kurdi, Ahmed M Majeed-Saidan, Muhammad Ali Al Rakaf, Maha S AlHashem, Amal M Botto, Lorenzo D Baaqeel, Hassan S Ammari, Amer N BMJ Open Epidemiology OBJECTIVE: To assess the three key issues for congenital anomalies (CAs) prevention and care, namely, CA prevalence, risk factor prevalence and survival, in a longitudinal cohort in Riyadh, Saudi Arabia. SETTING: Tertiary care centre, Riyadh, Saudi Arabia. PARTICIPANTS: Saudi women enrolled during pregnancy over 3 years and their 28 646 eligible pregnancy outcomes (births, stillbirths and elective terminations of pregnancy for foetal anomalies). The nested case-control study evaluated the CA risk factor profile of the underlying cohort. All CA cases (1179) and unaffected controls (1262) were followed through age 2 years. Referred mothers because of foetal anomaly and mothers who delivered outside the study centre and their pregnancy outcome were excluded. PRIMARY OUTCOME MEASURES: Prevalence and pattern of major CAs, frequency of CA-related risk factors and survival through age 2 years. RESULTS: The birth prevalence of CAs was 412/10 000 births (95% CI 388.6 to 434.9), driven mainly by congenital heart disease (148 per 10 000) (95% CI 134 to 162), renal malformations (113, 95% CI 110 to 125), neural tube defects (19, 95% CI 25.3 to 38.3) and chromosomal anomalies (27, 95% CI 21 to 33). In this study, the burden of potentially modifiable risk factors included high rates of diabetes (7.3%, OR 1.98, 95% CI 1.04 to 2.12), maternal age >40 years (7.0%, OR 2.1, 95% CI 1.35 to 3.3), consanguinity (54.5%, OR 1.5, 95% CI 1.28 to 1.81). The mortality for live births with CAs at 2 years of age was 15.8%. CONCLUSIONS: This study documented specific opportunities to improve primary prevention and care. Specifically, folic acid fortification (the neural tube defect prevalence was >3 times that theoretically achievable by optimal fortification), preconception diabetes screening and consanguinity-related counselling could have significant and broad health benefits in this cohort and arguably in the larger Saudi population. BMJ Publishing Group 2019-09-05 /pmc/articles/PMC6731804/ /pubmed/31492776 http://dx.doi.org/10.1136/bmjopen-2018-026351 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Epidemiology
Kurdi, Ahmed M
Majeed-Saidan, Muhammad Ali
Al Rakaf, Maha S
AlHashem, Amal M
Botto, Lorenzo D
Baaqeel, Hassan S
Ammari, Amer N
Congenital anomalies and associated risk factors in a Saudi population: a cohort study from pregnancy to age 2 years
title Congenital anomalies and associated risk factors in a Saudi population: a cohort study from pregnancy to age 2 years
title_full Congenital anomalies and associated risk factors in a Saudi population: a cohort study from pregnancy to age 2 years
title_fullStr Congenital anomalies and associated risk factors in a Saudi population: a cohort study from pregnancy to age 2 years
title_full_unstemmed Congenital anomalies and associated risk factors in a Saudi population: a cohort study from pregnancy to age 2 years
title_short Congenital anomalies and associated risk factors in a Saudi population: a cohort study from pregnancy to age 2 years
title_sort congenital anomalies and associated risk factors in a saudi population: a cohort study from pregnancy to age 2 years
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731804/
https://www.ncbi.nlm.nih.gov/pubmed/31492776
http://dx.doi.org/10.1136/bmjopen-2018-026351
work_keys_str_mv AT kurdiahmedm congenitalanomaliesandassociatedriskfactorsinasaudipopulationacohortstudyfrompregnancytoage2years
AT majeedsaidanmuhammadali congenitalanomaliesandassociatedriskfactorsinasaudipopulationacohortstudyfrompregnancytoage2years
AT alrakafmahas congenitalanomaliesandassociatedriskfactorsinasaudipopulationacohortstudyfrompregnancytoage2years
AT alhashemamalm congenitalanomaliesandassociatedriskfactorsinasaudipopulationacohortstudyfrompregnancytoage2years
AT bottolorenzod congenitalanomaliesandassociatedriskfactorsinasaudipopulationacohortstudyfrompregnancytoage2years
AT baaqeelhassans congenitalanomaliesandassociatedriskfactorsinasaudipopulationacohortstudyfrompregnancytoage2years
AT ammariamern congenitalanomaliesandassociatedriskfactorsinasaudipopulationacohortstudyfrompregnancytoage2years